Clinical trial
Naltrexone Treatment for Alcoholism
NCT00000438 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00000438 |
|---|---|
| Title | Naltrexone Treatment for Alcoholism |
| Official title | Naltrexone Treatment for Alcoholism: Predicting Outcome |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alcoholism |
| Intervention type | Drug |
| Interventions | naltrexone (Revia) |
| Enrollment | 192 |
| Completion | Mar 1, 2003 |
| First posted | Nov 3, 1999 |
| Last update posted | May 14, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: